Shanghai Hile Bio-Technology Balance Sheet Health
Financial Health criteria checks 4/6
Shanghai Hile Bio-Technology has a total shareholder equity of CN¥1.2B and total debt of CN¥60.9M, which brings its debt-to-equity ratio to 5%. Its total assets and total liabilities are CN¥1.6B and CN¥398.0M respectively.
Key information
5.0%
Debt to equity ratio
CN¥60.91m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥221.20m |
| Equity | CN¥1.23b |
| Total liabilities | CN¥398.05m |
| Total assets | CN¥1.62b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 603718's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥371.0M).
Long Term Liabilities: 603718's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥27.0M).
Debt to Equity History and Analysis
Debt Level: 603718 has more cash than its total debt.
Reducing Debt: 603718's debt to equity ratio has increased from 0% to 5% over the past 5 years.
Debt Coverage: 603718's debt is well covered by operating cash flow (116.2%).
Interest Coverage: Insufficient data to determine if 603718's interest payments on its debt are well covered by EBIT.